Evotec and Bristol Myers Squibb Advance Partnership After Second IND Acceptance
The FDA accepted a second investigational new drug application under the companies’ strategic protein degradation partnership.
The FDA accepted a second investigational new drug application under the companies’ strategic protein degradation partnership.